Lupkynis Interactions
There are 869 drugs known to interact with Lupkynis (voclosporin), along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 441 are major, 415 are moderate, and 13 are minor.
- View all 869 medications that may interact with Lupkynis
- View Lupkynis alcohol/food interactions (2)
- View Lupkynis disease interactions (8)
Most frequently checked interactions
View interaction reports for Lupkynis (voclosporin) and the medicines listed below.
- acetaminophen
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adderall XR (amphetamine / dextroamphetamine)
- Advil (ibuprofen)
- Adynovate (antihemophilic factor)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- albuterol
- Aleve (naproxen)
- Altoprev (lovastatin)
- amlodipine
- Benlysta (belimumab)
- Emgality (galcanezumab)
- Farxiga (dapagliflozin)
- folic acid
- Gilotrif (afatinib)
- hydroxychloroquine
- Imuran (azathioprine)
- Jardiance (empagliflozin)
- Lipitor (atorvastatin)
- lisinopril
- magnesium oxide
- metformin
- Mounjaro (tirzepatide)
- mycophenolate mofetil
- Plaquenil (hydroxychloroquine)
- prednisone
- Ubrelvy (ubrogepant)
Lupkynis alcohol/food interactions
There are 2 alcohol/food interactions with Lupkynis (voclosporin).
Lupkynis disease interactions
There are 8 disease interactions with Lupkynis (voclosporin) which include:
- infections
- liver dysfunction
- nephrotoxicity
- neurotoxicities
- PRCA
- QT prolongation
- vaccination
- Voclosporin – hypertension
Report options
QR code containing a link to this page
More about Lupkynis (voclosporin)
- Lupkynis consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: calcineurin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
